ClinVar Miner

Submissions for variant NM_006950.3(SYN1):c.1648G>A (p.Ala550Thr)

dbSNP: rs397514680
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000034816 SCV001554659 uncertain significance Epilepsy, X-linked 1, with variable learning disabilities and behavior disorders 2023-09-26 criteria provided, single submitter clinical testing In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies have shown that this missense change affects SYN1 function (PMID: 21441247, 26173895). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. ClinVar contains an entry for this variant (Variation ID: 41889). This variant is also known as p.Ala548Thr. This missense change has been observed in individuals with SYN1-related conditions (PMID: 21441247; Invitae). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate insufficient coverage at this position in the gnomAD database. This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 550 of the SYN1 protein (p.Ala550Thr).
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV003330407 SCV004039560 uncertain significance not specified 2023-08-15 criteria provided, single submitter clinical testing Variant summary: SYN1 c.1648G>A (p.Ala550Thr) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant was absent in 17090 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.1648G>A has been reported in the literature in individuals affected with epilepsy, autism spectrum disorder, and schizophrenia (examples: Fassio_2011, and Mojarad_2021). These report(s) do not provide unequivocal conclusions about association of the variant with Epilepsy, X-linked 1, with variable learning disabilities and behavior disorders. Experimental studies have reported the variant affects normal protein function however is insufficient to determine the role of this variant in disease (examples: Fassio_2011, and Tang_2014). The following publications have been ascertained in the context of this evaluation (PMID: 21441247, 33526774, 26173895). One submitter has cited clinical-significance assessments for this variant to ClinVar after 2014 and has classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance.
PreventionGenetics, part of Exact Sciences RCV003952400 SCV004773657 uncertain significance SYN1-related condition 2024-02-08 criteria provided, single submitter clinical testing The SYN1 c.1648G>A variant is predicted to result in the amino acid substitution p.Ala550Thr. This variant has been reported to be causative for autism spectrum disorders with or without epilepsy in four unrelated French Canadian patients (Fassio et al. 2011 et al. PubMed ID: 21441247). Functional studies showed that this variant displayed impaired targeting to nerve terminals (Fassio et al. 2011 et al. PubMed ID: 21441247; Tang et al. 2015. PubMed ID: 26173895, reported as A548T). This variant has not been reported in a large population database, indicating this variant is rare. However, it has conflicting interpretations regarding its pathogenicity in ClinVar, ranging from pathogenic to uncertain significance (https://www.ncbi.nlm.nih.gov/clinvar/variation/41889/). Although we suspect that this variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.
OMIM RCV000034816 SCV000058378 pathogenic Epilepsy, X-linked 1, with variable learning disabilities and behavior disorders 2011-06-15 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.